Gene

Genetic Technologies is a diversified molecular diagnostics company that specializes in genomics-based tests for health, wellness, and serious disease risk assessment. The company is best known for its geneType platform, which integrates clinical risk factors with polygenic risk scores to provide a comprehensive assessment of an individual's risk for developing various chronic diseases, including several types of cancer and cardiovascular conditions. Headquartered in Australia with a significant presence in the United States, Genetic Technologies offers a suite of predictive tests designed to empower physicians and patients with actionable insights for proactive health management. Their product portfolio includes the BREVAGenplus test for non-hereditary breast cancer and the EasyDNA brand, which provides a wide range of DNA testing services directly to consumers.